BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 24970683)

  • 21. Long-term oncological outcomes of patients with negative sentinel lymph node in vulvar cancer. Comparative study with conventional lymphadenectomy.
    Rodríguez-Trujillo A; Fusté P; Paredes P; Mensión E; Agustí N; Gil-Ibáñez B; Del Pino M; González-Bosquet E; Torné A
    Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1427-1437. PubMed ID: 30063814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.
    Van der Zee AG; Oonk MH; De Hullu JA; Ansink AC; Vergote I; Verheijen RH; Maggioni A; Gaarenstroom KN; Baldwin PJ; Van Dorst EB; Van der Velden J; Hermans RH; van der Putten H; Drouin P; Schneider A; Sluiter WJ
    J Clin Oncol; 2008 Feb; 26(6):884-9. PubMed ID: 18281661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to extend the indication for sentinel node biopsy in vulvar cancer? Results from a prospective nationwide Swedish study.
    Zach D; Stenström Bohlin K; Kannisto P; Moberg L; Kjölhede P
    Int J Gynecol Cancer; 2023 Dec; 33(12):1845-1852. PubMed ID: 37918956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe.
    Van der Kolk WL; Van der Zee AGJ; Slomovitz BM; Baldwin PJW; Van Doorn HC; De Hullu JA; Van der Velden J; Gaarenstroom KN; Slangen BFM; Kjolhede P; Brännström M; Vergote I; Holland CM; Coleman R; Van Dorst EBL; Van Driel WJ; Nunns D; Widschwendter M; Nugent D; DiSilvestro PA; Mannel RS; Tjiong MY; Boll D; Cibula D; Covens A; Provencher D; Runnebaum IB; Monk BJ; Zanagnolo V; Tamussino K; Oonk MHM;
    Gynecol Oncol; 2022 Oct; 167(1):3-10. PubMed ID: 36085090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study.
    Oonk MH; van Hemel BM; Hollema H; de Hullu JA; Ansink AC; Vergote I; Verheijen RH; Maggioni A; Gaarenstroom KN; Baldwin PJ; van Dorst EB; van der Velden J; Hermans RH; van der Putten HW; Drouin P; Runnebaum IB; Sluiter WJ; van der Zee AG
    Lancet Oncol; 2010 Jul; 11(7):646-52. PubMed ID: 20537946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection.
    Martínez-Palones JM; Gil-Moreno A; Pérez-Benavente MA; Roca I; Xercavins J
    Gynecol Oncol; 2004 Mar; 92(3):845-50. PubMed ID: 14984951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential risk of contralateral non-sentinel groin node metastasis in women with early primary vulvar cancer following unilateral sentinel node metastasis: a single center evaluation in University Hospital of Düsseldorf.
    Winarno AS; Mondal A; Martignoni FC; Fehm TN; Hampl M
    BMC Womens Health; 2021 Jan; 21(1):23. PubMed ID: 33435958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of intraoperative injection of radioactive tracer and blue dye for sentinel lymph node biopsy in vulvar cancer.
    Garrett AA; Ricciuti J; Lang SM; Burriss ME; Flanigan M; O'Brien E; Hay C; Lesnock J; Berger JL; Taylor SE
    Gynecol Oncol; 2023 Aug; 175():41-44. PubMed ID: 37321154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024).
    Gien LT; Slomovitz B; Van der Zee A; Oonk M
    Int J Gynecol Cancer; 2023 Apr; 33(4):619-622. PubMed ID: 36653060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The usefulness of sentinel lymph node detection in vulvar cancer - a short communication.
    Sawicki S; Romanowicz G; Wydra D; Lass P
    Nucl Med Rev Cent East Eur; 2010; 13(2):81-3. PubMed ID: 21598232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study.
    Ansink AC; Sie-Go DM; van der Velden J; Sijmons EA; de Barros Lopes A; Monaghan JM; Kenter GG; Murdoch JB; ten Kate FJ; Heintz AP
    Cancer; 1999 Aug; 86(4):652-6. PubMed ID: 10440693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inguinofemoral sentinel lymph node biopsy by scar injection in vulvar cancer: an assessment of feasibility and long-term outcomes.
    Pascoal E; Alyafi M; Pokoradi A; Eiriksson L; Helpman L
    Int J Gynecol Cancer; 2022 Dec; 32(12):1512-1518. PubMed ID: 36332935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.
    Bodurtha Smith AJ; Fader AN; Tanner EJ
    Am J Obstet Gynecol; 2017 May; 216(5):459-476.e10. PubMed ID: 27871836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial.
    Moore RG; Robison K; Brown AK; DiSilvestro P; Steinhoff M; Noto R; Brard L; Granai CO
    Gynecol Oncol; 2008 Apr; 109(1):65-70. PubMed ID: 18255128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel node biopsy in early vulvar cancer.
    De Cicco C; Sideri M; Bartolomei M; Grana C; Cremonesi M; Fiorenza M; Maggioni A; Bocciolone L; Mangioni C; Colombo N; Paganelli G
    Br J Cancer; 2000 Jan; 82(2):295-9. PubMed ID: 10646880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
    Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
    Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution and outcomes of sentinel lymph node mapping in vulvar cancer.
    Broach V; Abu-Rustum NR; Sonoda Y; Brown CL; Jewell E; Gardner G; Chi DS; Zivanovic O; Leitao MM
    Int J Gynecol Cancer; 2020 Mar; 30(3):383-386. PubMed ID: 32075896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of recurrence, complication and survival rates in patients with early stage vulval cancer undergoing sentinel lymph node sampling: a single-centre experience.
    Katsanevakis E; Joshi A; Ong ZZ; O'Connor R; Nunns D; Gajjar K
    Arch Gynecol Obstet; 2023 Aug; 308(2):561-567. PubMed ID: 36854984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
    Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.